Journal
VACCINE
Volume 34, Issue 12, Pages 1472-1479Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2016.01.041
Keywords
Flagellin((1-161)); AuNPs; Pseudomonas aeruginosa
Categories
Funding
- Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
Ask authors/readers for more resources
Flagellin of Pseudomonas aeruginosa is an important vaccine candidate. N-terminal domains are highly conserved in both type a and type b flagellins. The efficacy of gold nanoparticles (AuNPs) conjugated to N-terminal domains of P. aeruginosa flagellin (flagellin((1-161))), as an immunogen in mice, has been assessed. The nanoparticles were conjugated to the recombinant protein through direct interaction of thiol molecules of the cysteines with AuNPs and formation of Au-S bond. Flagellin((1-161)), AuNP-flagellin((1-161)), and flagellin((1-161)) emulsified in Freund's adjuvant (FA: complete/incomplete Freund's adjuvant formulation) were administered subcutaneously to BALB/c mice. Mice given AuNP-flagellin((1-161)) elicited high titers of anti-flagellin((1-161)) antibodies compared with non-immune group and/or mice which received flagellin((1-161)) without adjuvant. In whole cell ELISA, these antibodies effectively recognized the native flagellin on the bacteria. Opsonophagocytosis assay demonstrated the functional activity and specificity of anti-flagellin((1-161)) antibodies raised by AuNP-flagellin((1-161)) against homologous strain. All of the results were comparable with those obtained by use of FA. Taken together, this is the first report of conjugation of AuNPs to flagellin and evaluating its immune response against P. aeruginosa. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available